H. LadelChristoph

Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future.

M. Karsdal, C. Christiansen, V. Kraus, 2016, Osteoarthritis and cartilage.

Osteoarthritis year in review 2015: soluble biomarkers and the BIPED criteria.

M. Karsdal, A. Mobasheri, Y. Henrotin, 2016, Osteoarthritis and cartilage.

Sprifermin (rhFGF18) enables proliferation of chondrocytes producing a hyaline cartilage matrix.

M. Karsdal, A. Gigout, C. Ladel, 2017, Osteoarthritis and cartilage.

Predictive and concurrent validity of cartilage thickness change as a marker of knee osteoarthritis progression: data from the Osteoarthritis Initiative.

F Eckstein, W Wirth, D J Hunter, 2017, Osteoarthritis and cartilage.